Title |
Bispecific Antibody Pretargeting for Therapy
|
Institution |
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY, BELLEVILLE, NJ
|
Principal Investigator |
SHARKEY, ROBERT
|
NCI Program Director |
Heng Xie
|
Cancer Activity |
Clinical Oncology
|
Division |
DCTD
|
Funded Amount |
$512,569
|
Project Dates |
03/01/2006 - 02/28/2010
|
Fiscal Year |
2008
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
Chemotherapy (100.0%)
Digestive Diseases (100.0%)
Monoclonal Antibodies (100.0%)
|
Colon/Rectum (100.0%)
|
Research Type |
Systemic Therapies - Clinical Applications
|
Abstract |
No abstract available. |